2-HYDROXYPYRIDINE; Pyridin-2-ol; 142-08-5; 2-Pyridinol; 2-Pyridone; pyridin-2(1H)-one; 72762-00-6; 2(1H)-Pyridinone; 1H-pyridin-2-one; 2-Pyridinone; 2(1H)-Pyridone; Pyridinone; alpha-Pyridone; 2-Oxopyridine; pyridin-2-one; Pyridone-2; 2-hydroxy pyridine; .alpha.-Pyridone; Pyridinol; Levetiracetam Impurity C; 2-Pyridol; CHEBI:16540; 1-Hydroxy-2-pyridine; 1~{H}-pyridin-2-one; CHEMBL662; 1,2-dihydropyridin-2-one; SR-1C9; DTXSID2051716; MFCD00006268; NSC172522; 6770O3A2I5; NSC-172522; 2(lH)-Pyridinone; Pyridone-2 [French]; Hydroxypyridine; 66396-89-2; EINECS 205-520-3; NSC 172522; pyrdinone; hydroxylpyridine; alpha -pyridone; hydroxy-pyridine; AI3-19236; pyridinyl alcohol; 2-hyroxypyridine; UNII-6770O3A2I5; 2-hydroxypryidine; lH-2-pyridone; pyrid-2-one; 2-pyridyl alcohol; 2-hydroxy-pyridine; HRZ; T5Y; (1H)-pyridone; 2-hydroxyl pyridine; EINECS 276-824-1; pyridin2(1h)-one; 1H-2-Pyridone; 2H-pyridin-2-one; 2-(1H)-pyridone; 1-H-pyridin-2-one; pyridin-2 (1h)-one; 1,2-dihydro-oxopyridine; 930-70-1; 2(1H)-Pyridone, dimer; 2-Hydroxypyridine, 97%; HYDROXYPYRIDINE, 2-; DTXCID2030271; 2-Pyridinol (ACD/Name 4.0); ACT08592; ZINC8737707; Tox21_303883; BBL027571; BDBM50538683; MFCD00462283; NSC176167; s6360; STL146648; 2-Hydroxypyridine, analytical standard; AKOS000119122; AKOS016352898; NSC-176167; SB52270; SB52273; NCGC00357141-01; CAS-142-08-5; DB-015956; DS-003023; AM20061675; FT-0612635; FT-0654997; H0330; EN300-21469; LEVETIRACETAM IMPURITY C [EP IMPURITY]; 2-Hydroxypyridine, purum, >=97.0% (HPLC); C02502; D87632; P20525; A837610; A929205; AC-907/25014059; Q209474; W-108179; F1995-0210; Z1245646663; LEVETIRACETAM IMPURITY, PYRIDIN-2-OL- [USP IMPURITY]; B910DA2F-8676-4873-9F5A-7A9091749198; Levetiracetam impurity C, European Pharmacopoeia (EP) Reference Standard; 27341-45-3